{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P10275",
      "entity_text" : "AR",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:6013",
      "entity_text" : "testosterone",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "Cellular_component" : [ "go:GO:0043226" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "The main agent in this class is enzalutamide (MDV-3100, ENZA, Xtandi), which has been demonstrated to have a multi pronged approach--preventing testosterone binding to AR, AR nuclear translocation, AR binding to DNA, and co-activator recruitment.",
  "reading_complete" : "2020-08-04T13:31:44Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T13:29:20Z",
  "trigger" : "binding",
  "evidence" : [ "testosterone binding to AR" ],
  "pmc_id" : "4708226",
  "score" : 0
}